TRL levels are a 1 to 9 scale for technology maturity, from basic principles observed to a system proven in an operational environment. For founders, TRL affects which grants to search for, what evidence reviewers expect, and whether a project is too early or too mature for a call.
TRL is useful because it separates technical maturity from company maturity. A startup can have strong founders and a large market while the technology itself is still too early for demonstration or scale-up funding.
Use this guide with the deeptech funding roadmap and the grant search workflow.
Meaning
TRL is not a fundraising score. It is a maturity language that helps funders understand what has been proven, in what environment, and what risk remains.
Founders often use TRL as a badge: "we are TRL 6" or "we need funding to reach TRL 8." Reviewers use it differently. They ask what was demonstrated, under what conditions, by whom, and whether the evidence is strong enough for the next stage of funding. A claimed TRL without evidence is just a label.
The scale was popularized in aerospace and government R&D contexts, but the underlying idea is broadly useful. It gives teams a shared vocabulary for moving from scientific possibility to operational proof. For deeptech startups, that vocabulary helps align grants, pilots, investors, customers, and technical teams.
The most useful way to think about TRL is as a risk map. Early TRLs are about whether the scientific principle works. Middle TRLs are about whether an integrated prototype can work outside a clean research setting. Later TRLs are about whether the full system can survive real operating conditions with repeatability, reliability, and customer relevance. Each step changes the kind of evidence a funder expects.
This matters because many deeptech applications fail by talking about the wrong risk. A founder may spend pages explaining market size when the reviewer is worried that the prototype has never been tested outside the lab. Another founder may describe technical detail when the funder is asking whether the proposed work will move the technology into a relevant environment. TRL helps you choose the right emphasis.
TRL table
| TRL | Plain-English meaning | Founder evidence |
|---|---|---|
| 1 | Basic principle observed. | Scientific rationale, early literature, initial hypothesis. |
| 2 | Technology concept formulated. | Concept model and possible application. |
| 3 | Experimental proof of concept. | Early experiment showing the principle can work. |
| 4 | Component validated in lab. | Lab prototype or subsystem test. |
| 5 | Component validated in relevant environment. | Prototype tested under more realistic conditions. |
| 6 | System demonstrated in relevant environment. | Integrated prototype with credible performance data. |
| 7 | System prototype demonstrated operationally. | Pilot or field demonstration. |
| 8 | System complete and qualified. | Validated product or process ready for first deployment. |
| 9 | System proven in operational use. | Real customer or operational deployment evidence. |
The table is a guide, not a substitute for judgment. In software-heavy deeptech, the boundary between simulated, relevant, and operational environments can be blurry. In hardware, materials, climate, aerospace, diagnostics, robotics, and energy, the boundary is usually more concrete because the operating environment introduces physical constraints: temperature, vibration, contamination, duty cycle, regulation, safety, durability, or manufacturing yield.
For a grant application, the best TRL explanation is usually specific rather than formal. Instead of writing only "we are TRL 5," say what has been validated, where it was validated, and what remains unproven. Reviewers can then see whether the proposed work is a credible bridge to the next level.
Estimate TRL
The safest way to estimate TRL is to start lower than your instinct. Ask what has actually been shown, not what the team can reasonably build next. If a component works in the lab but the integrated system has not been tested, the system TRL is lower than the component TRL. If a prototype works in a friendly demo but not in the real operating environment, the TRL is not yet a deployment TRL.
- Write what has actually been demonstrated, not what the team believes is possible.
- Name the environment: paper, lab, bench, simulated, relevant, pilot, operational.
- Separate component evidence from full-system evidence.
- Document who generated the evidence and whether it is independent.
- Use the lower TRL if two parts of the system are at different maturity levels.
A good TRL statement includes three pieces: current TRL, target TRL, and evidence. For example: "The sensing component is currently TRL 4 based on controlled lab validation; the project aims to reach TRL 5 by testing the integrated prototype under field-relevant temperature and vibration conditions." That sentence is more useful than claiming a high TRL without context.
The current TRL and target TRL should not be invented at the end of writing. They should shape the work plan. If the current state is TRL 4 and the project aims for TRL 6, the work packages should show integration, relevant-environment testing, performance metrics, and evidence capture. If the work packages only describe design activity, literature review, or customer discovery, the target TRL is probably too ambitious. Use the grant work plan template to make the maturity step visible.
A practical founder exercise is to write one sentence for each critical subsystem. What is the subsystem, what evidence exists, what environment was used, and what would have to be true before the full product can be considered at the next TRL? The lowest-maturity critical subsystem often determines the project risk. That is the part reviewers will notice even if the rest of the company looks mature.
Evidence
TRL moves when evidence moves. A plan to test is not the same as a test result.
| Evidence | What it can support | What it cannot support alone |
|---|---|---|
| Scientific literature | TRL 1-2 rationale and technical plausibility. | A claim that your specific product works. |
| Bench experiment | Early proof of concept and component performance. | Operational readiness. |
| Integrated prototype | System-level maturity if the test conditions are relevant. | Manufacturing readiness or customer adoption. |
| Pilot deployment | Operational learning and adoption evidence. | Full scale economics unless costs and repeatability are measured. |
| Independent validation | Credibility with reviewers, customers, and investors. | A complete business case without market evidence. |
Evidence quality matters. Internal data can be enough for early grants, but later-stage funders may expect independent testing, customer pilots, certification progress, manufacturing data, or real operating history. The higher the TRL claim, the more the evidence should resemble the real world. The proof-of-concept data guide gives a practical structure for recording those claims, files, and limitations.
Good evidence also has a timestamp and a method. Reviewers want to know whether a test was recent, whether the sample size was meaningful, whether the conditions were representative, whether the result can be repeated, and whether failure modes were recorded. A single successful demo may be exciting, but a documented test series is stronger.
Do not hide negative results. In technical grant writing, a known failure mode can make the project more credible if the work plan addresses it directly. For example, a robotics startup that has documented failure under wet outdoor conditions can propose environmental hardening and field validation. That is stronger than pretending the current prototype is already operational.
Grant fit
| TRL range | Usually fits | Usually too early or late for |
|---|---|---|
| TRL 1-2 | Research, scientific validation, university-linked funding. | Commercial scale-up grants. |
| TRL 3-4 | Proof-of-concept, feasibility, early SBIR/STTR-style R&D. | Deployment funding. |
| TRL 5-6 | Prototype, relevant-environment validation, demonstration planning. | Pure discovery research grants. |
| TRL 6-8 | Demonstration, EIC Accelerator-style innovation funding, pilots. | Very early feasibility-only calls. |
| TRL 8-9 | Scale-up, procurement, customers, VC, project finance. | Early R&D grants. |
Funders may use TRL differently. EIC guidance, for example, also cares about market and business readiness. A good application explains technology readiness and commercial readiness separately.
This is the practical reason TRL matters for grant search. If a call funds feasibility work, a TRL 7 project may look too mature. If a call funds demonstration and scale-up, a TRL 3 project may look too early. A mismatch can kill an application even when the technology is promising.
When screening opportunities, read the call text for verbs. Words like explore, feasibility, validate, de-risk, demonstrate, pilot, deploy, scale, and commercialize usually imply different maturity expectations. A call that asks for demonstration with end users is rarely asking for a literature-backed concept. A call that asks for early feasibility is rarely asking for a product that is already commercially deployed.
The funding amount is another clue. Small grants often support a narrow evidence step: feasibility, prototype refinement, or validation. Larger innovation grants usually expect a bigger jump: integrated demonstration, market validation, regulatory planning, and commercialization. If the budget is large but the evidence base is weak, reviewers may see the project as underprepared.
Market readiness
TRL tells you whether the technology is maturing. It does not tell you whether customers will buy, regulators will approve, suppliers can deliver, or the unit economics work.
A deeptech company can be high TRL and still commercially weak. It may have a working system but no buyer urgency, no channel, poor margins, unresolved certification, or a deployment workflow customers cannot adopt. The reverse can also happen: the market need can be urgent while the technology is still early. Strong grant applications explain both sides.
| Readiness type | Question | Evidence |
|---|---|---|
| Technology readiness | Does it work in the required environment? | TRL evidence, tests, prototype results, validation data. |
| Market readiness | Does someone need it enough to adopt? | Customer interviews, pilots, letters, procurement signals. |
| Manufacturing readiness | Can it be made reliably and economically? | Yield, suppliers, process data, quality controls. |
| Regulatory readiness | Can it pass the required approval or compliance path? | Standards map, regulatory plan, pre-submission feedback. |
| Business readiness | Can the company turn the technology into a viable business? | Pricing, margins, route to market, team, financing plan. |
When a funder asks for impact, commercialization, or business readiness, do not answer only with TRL. Explain how the next technical milestone changes market adoption. For example, moving from TRL 5 to TRL 6 may unlock a pilot; moving from TRL 6 to TRL 7 may support procurement or investor diligence.
Examples
TRL is easiest to understand through examples. The exact level can vary by sector, but the reasoning pattern is the same: what was demonstrated, in what environment, and how close is that environment to real use?
| Startup type | Likely current TRL | What would move it up |
|---|---|---|
| AI model for industrial inspection tested only on internal historical images. | TRL 3-4 | Validation on customer data, edge-case testing, and pilot deployment in a real inspection workflow. |
| Battery material with strong lab-cell performance but no pouch-cell or cycle-life validation. | TRL 3-4 | Relevant-format cell testing, repeatability, degradation data, and manufacturability evidence. |
| Robotics prototype demonstrated in a controlled lab course. | TRL 4-5 | Relevant-environment testing with real obstacles, duty cycles, operators, and failure modes. |
| Medtech diagnostic with analytical validation but no clinical workflow evidence. | TRL 4-6 | Clinical sample validation, usability evidence, regulatory planning, and partner workflow testing. |
| Climate sensor installed with a design partner for continuous field operation. | TRL 6-7 | Longer-duration operational data, reliability metrics, customer acceptance, and production plan. |
The point is not to argue for the highest possible number. The point is to choose the funding path that matches the real maturity. A TRL 4 company that claims TRL 7 may lose trust. A TRL 4 company that clearly explains how grant funding will reach TRL 5 or 6 can look much stronger.
This is especially important when multiple parts of the product mature at different speeds. The algorithm may be ready, but the sensor package may not. The chemistry may be validated, but the manufacturing process may not. The prototype may work, but the installation workflow may fail. Grant applications should be honest about the lowest-maturity critical path.
Application language
In a grant application, TRL language should make the reviewer trust your judgment. State the current maturity, the evidence behind it, the target maturity, and why the proposed work is the right bridge.
Avoid treating TRL as a single number dropped into the application. The number is useful only when the surrounding narrative explains it. A strong paragraph usually has four parts: what exists today, what has been proven, what has not yet been proven, and what the funded project will prove next.
| Weak phrasing | Stronger phrasing |
|---|---|
| Our technology is TRL 6 and ready for scale-up. | The integrated prototype has reached TRL 5 based on lab-relevant validation; the project will target TRL 6 through testing in a customer-representative environment. |
| We will advance the product to TRL 8. | The work plan will move the sensing subsystem from TRL 4 to TRL 5 and the integrated platform from TRL 3 to TRL 5, creating the evidence needed for a later field demonstration. |
| The product has been validated. | The core algorithm has been validated on historical customer data; the deployment workflow, edge hardware, and operator interface still require pilot validation. |
| The market is ready for this technology. | Customer interviews and pilot letters show demand, but adoption depends on proving reliability under operating conditions and reducing installation time below the target threshold. |
This style of writing is more cautious, but it is also more fundable. It shows the reviewer that the team understands the gap between invention and deployment. It also prevents the application from overpromising. Deeptech reviewers tend to be comfortable with risk; they are less comfortable with teams that cannot describe their risk precisely.
If the form asks for both objectives and expected outcomes, use TRL to connect them. Objectives describe the work: integrate the prototype, run environmental tests, complete pilot validation, document performance, or prepare regulatory evidence. Outcomes describe the maturity shift: the project will produce TRL 5 evidence for the subsystem, TRL 6 evidence for the integrated prototype, or operational data needed for first customer deployment.
The same logic applies to milestones. A milestone should not say only "prototype complete." It should say what evidence will prove completion. For example: "integrated prototype tested for 200 operating hours under representative humidity and temperature conditions with less than 3% performance drift." That kind of milestone gives reviewers something concrete to score.
For investor-facing materials, the tone can be shorter, but the structure is similar. Investors may not care about the formal TRL number, yet they care deeply about what has been de-risked. A roadmap that says "TRL 4 to TRL 6 over 12 months" should translate into specific diligence points: product performance, customer validation, manufacturing path, regulatory timeline, and capital required after the grant.
Mistakes
| Mistake | Why it matters | Fix |
|---|---|---|
| Claiming TRL based on ambition | Reviewers score evidence, not plans. | State the current proven TRL and the target TRL after funding. |
| Confusing component TRL with system TRL | One mature part does not make the full product mature. | Break the system into critical components. |
| Ignoring market readiness | Technology readiness alone does not prove adoption. | Add customer, regulatory, manufacturing, and business evidence. |
| Applying to the wrong stage | The project can be rejected even if the technology is strong. | Match the call to the TRL and next evidence milestone. |
